ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,358.25
-0.32%
Dow Jones
43,190.47
-0.11%
Gold vs US Dollar
2,714.12
0.75%
Brent Oil
72.615
-2.08%
Bitcoin
68,821.21
2.08%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Zealand Pharma AS (22Z) Share Price

22Z Zealand Pharma AS

108.70
2.00 (1.87%)
16:57:10 - Realtime Data
 Name  Symbol  Market  Type  ISIN  Description 
 Zealand Pharma AS TG:22Z Tradegate (DE) Ordinary Share DK0060257814 
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time  RN  NRN 
   2.00 1.87 108.70 107.70 108.60 108.70 104.00 107.1 760 15:57:10   
 Type  Size  Price  Time  Units 
  1 108.70 15:44:20 EUR
 
Recent News
DateTimeSource
HeadlineMore 22Z News
08/10/202423:45UKREGZealand Pharma provides U.S. regulatory update on dasiglucagon in congenital hyperinsulinism
08/10/202407:40UKREGZealand Pharma announces that Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two Phase III trials in MASH for survodutide
30/09/202416:00UKREGTotal number of shares and voting rights in Zealand Pharma A/S on September 30, 2024
12/09/202416:01UKREGZealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
09/09/202416:01UKREGZealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
30/08/202421:00UKREGTransactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
30/08/202416:00UKREGTotal number of shares and voting rights in Zealand Pharma on August 30, 2024
Period
Draw mode
Data Downloads for 22Z

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Zealand Pharma AS Articles